nodes	percent_of_prediction	percent_of_DWPC	metapath
Lidocaine—EGFR—lung cancer	0.164	0.472	CbGaD
Lidocaine—CYP2A6—lung cancer	0.134	0.385	CbGaD
Lidocaine—EGFR—Gefitinib—lung cancer	0.106	0.234	CbGbCtD
Lidocaine—EGFR—Erlotinib—lung cancer	0.0625	0.139	CbGbCtD
Lidocaine—ABCB1—lung cancer	0.0498	0.143	CbGaD
Lidocaine—EGFR—Docetaxel—lung cancer	0.0414	0.0917	CbGbCtD
Lidocaine—CYP3A5—Gefitinib—lung cancer	0.00968	0.0214	CbGbCtD
Lidocaine—CYP3A5—Teniposide—lung cancer	0.00938	0.0208	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.00698	0.0155	CbGbCtD
Lidocaine—CYP3A7—Paclitaxel—lung cancer	0.00698	0.0155	CbGbCtD
Lidocaine—CYP3A7—Irinotecan—lung cancer	0.00689	0.0153	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.00689	0.0153	CbGbCtD
Lidocaine—ABCB1—Topotecan—lung cancer	0.00688	0.0153	CbGbCtD
Lidocaine—CYP2B6—Irinotecan—lung cancer	0.00656	0.0145	CbGbCtD
Lidocaine—CYP2C9—Gefitinib—lung cancer	0.00649	0.0144	CbGbCtD
Lidocaine—ABCB1—Gefitinib—lung cancer	0.0063	0.014	CbGbCtD
Lidocaine—CYP2C9—Teniposide—lung cancer	0.00629	0.0139	CbGbCtD
Lidocaine—CYP2D6—Gefitinib—lung cancer	0.00593	0.0131	CbGbCtD
Lidocaine—CYP3A5—Crizotinib—lung cancer	0.00593	0.0131	CbGbCtD
Lidocaine—CYP3A5—Erlotinib—lung cancer	0.00572	0.0127	CbGbCtD
Lidocaine—CYP2C8—Erlotinib—lung cancer	0.0055	0.0122	CbGbCtD
Lidocaine—CYP2B6—Cisplatin—lung cancer	0.00535	0.0118	CbGbCtD
Lidocaine—CYP3A5—Paclitaxel—lung cancer	0.00524	0.0116	CbGbCtD
Lidocaine—CYP3A5—Irinotecan—lung cancer	0.00517	0.0114	CbGbCtD
Lidocaine—CYP3A7—Docetaxel—lung cancer	0.00505	0.0112	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.00505	0.0112	CbGbCtD
Lidocaine—CYP2C8—Paclitaxel—lung cancer	0.00504	0.0112	CbGbCtD
Lidocaine—ABCB1—Vinorelbine—lung cancer	0.00485	0.0108	CbGbCtD
Lidocaine—CYP2D6—Vinorelbine—lung cancer	0.00457	0.0101	CbGbCtD
Lidocaine—CYP1A2—Erlotinib—lung cancer	0.00426	0.00944	CbGbCtD
Lidocaine—CYP3A5—Etoposide—lung cancer	0.00414	0.00917	CbGbCtD
Lidocaine—CYP3A4—Topotecan—lung cancer	0.00413	0.00914	CbGbCtD
Lidocaine—CYP2C8—Etoposide—lung cancer	0.00398	0.00882	CbGbCtD
Lidocaine—ABCB1—Crizotinib—lung cancer	0.00386	0.00855	CbGbCtD
Lidocaine—CYP3A5—Docetaxel—lung cancer	0.00379	0.00839	CbGbCtD
Lidocaine—CYP3A4—Gefitinib—lung cancer	0.00377	0.00836	CbGbCtD
Lidocaine—ABCB1—Gemcitabine—lung cancer	0.00377	0.00836	CbGbCtD
Lidocaine—ABCB1—Erlotinib—lung cancer	0.00372	0.00825	CbGbCtD
Lidocaine—CYP3A4—Teniposide—lung cancer	0.00366	0.00811	CbGbCtD
Lidocaine—CYP2B6—Doxorubicin—lung cancer	0.00358	0.00794	CbGbCtD
Lidocaine—CYP2C9—Paclitaxel—lung cancer	0.00351	0.00778	CbGbCtD
Lidocaine—CYP2D6—Erlotinib—lung cancer	0.00351	0.00777	CbGbCtD
Lidocaine—ABCB1—Paclitaxel—lung cancer	0.00341	0.00755	CbGbCtD
Lidocaine—ABCB1—Irinotecan—lung cancer	0.00336	0.00745	CbGbCtD
Lidocaine—CYP1A2—Etoposide—lung cancer	0.00308	0.00683	CbGbCtD
Lidocaine—ABCB1—Vinblastine—lung cancer	0.00299	0.00663	CbGbCtD
Lidocaine—CYP3A4—Vinorelbine—lung cancer	0.00291	0.00644	CbGbCtD
Lidocaine—CYP2C9—Cisplatin—lung cancer	0.00282	0.00626	CbGbCtD
Lidocaine—CYP2D6—Vinblastine—lung cancer	0.00282	0.00624	CbGbCtD
Lidocaine—ABCB1—Cisplatin—lung cancer	0.00274	0.00607	CbGbCtD
Lidocaine—ABCB1—Etoposide—lung cancer	0.00269	0.00597	CbGbCtD
Lidocaine—ABCB1—Docetaxel—lung cancer	0.00246	0.00546	CbGbCtD
Lidocaine—CYP3A4—Crizotinib—lung cancer	0.00231	0.00513	CbGbCtD
Lidocaine—CYP3A4—Erlotinib—lung cancer	0.00223	0.00494	CbGbCtD
Lidocaine—CYP3A4—Paclitaxel—lung cancer	0.00204	0.00453	CbGbCtD
Lidocaine—CYP3A4—Irinotecan—lung cancer	0.00201	0.00446	CbGbCtD
Lidocaine—ABCB1—Doxorubicin—lung cancer	0.00184	0.00407	CbGbCtD
Lidocaine—CYP3A4—Vinblastine—lung cancer	0.00179	0.00397	CbGbCtD
Lidocaine—ABCB1—Methotrexate—lung cancer	0.00178	0.00394	CbGbCtD
Lidocaine—CYP2D6—Doxorubicin—lung cancer	0.00173	0.00384	CbGbCtD
Lidocaine—CYP3A4—Etoposide—lung cancer	0.00161	0.00358	CbGbCtD
Lidocaine—CYP3A4—Docetaxel—lung cancer	0.00148	0.00327	CbGbCtD
Lidocaine—CYP3A4—Doxorubicin—lung cancer	0.0011	0.00244	CbGbCtD
Lidocaine—EGFR—mammary gland—lung cancer	0.000714	0.137	CbGeAlD
Lidocaine—CYP2C18—bronchus—lung cancer	0.000338	0.0651	CbGeAlD
Lidocaine—EGFR—lung—lung cancer	0.000253	0.0486	CbGeAlD
Lidocaine—SLC22A5—mammary gland—lung cancer	0.000236	0.0455	CbGeAlD
Lidocaine—CYP2C8—mammary gland—lung cancer	0.000229	0.044	CbGeAlD
Lidocaine—SCN9A—lung—lung cancer	0.000208	0.04	CbGeAlD
Lidocaine—CYP2C9—mammary gland—lung cancer	0.000203	0.0391	CbGeAlD
Lidocaine—SCN5A—cardiac atrium—lung cancer	0.000188	0.0362	CbGeAlD
Lidocaine—EGFR—lymph node—lung cancer	0.000173	0.0332	CbGeAlD
Lidocaine—SCN3A—bone marrow—lung cancer	0.000159	0.0306	CbGeAlD
Lidocaine—SCN10A—lung—lung cancer	0.000158	0.0305	CbGeAlD
Lidocaine—SLC22A5—respiratory system—lung cancer	0.000158	0.0303	CbGeAlD
Lidocaine—SCN3A—lung—lung cancer	0.000144	0.0278	CbGeAlD
Lidocaine—CYP2A6—lung—lung cancer	0.000144	0.0277	CbGeAlD
Lidocaine—CYP1A2—respiratory system—lung cancer	0.000143	0.0274	CbGeAlD
Lidocaine—SCN9A—lymph node—lung cancer	0.000142	0.0274	CbGeAlD
Lidocaine—CYP3A5—respiratory system—lung cancer	0.000138	0.0265	CbGeAlD
Lidocaine—CYP2B6—respiratory system—lung cancer	0.000137	0.0263	CbGeAlD
Lidocaine—SLC22A5—bronchus—lung cancer	0.00013	0.0249	CbGeAlD
Lidocaine—SLC22A5—trachea—lung cancer	0.000116	0.0224	CbGeAlD
Lidocaine—CYP2B6—bronchus—lung cancer	0.000113	0.0216	CbGeAlD
Lidocaine—SLC22A5—cardiac atrium—lung cancer	0.000109	0.021	CbGeAlD
Lidocaine—SCN10A—lymph node—lung cancer	0.000108	0.0208	CbGeAlD
Lidocaine—SCN3A—lymph node—lung cancer	9.88e-05	0.019	CbGeAlD
Lidocaine—SLC22A5—lung—lung cancer	8.37e-05	0.0161	CbGeAlD
Lidocaine—Hyperhidrosis—Gemcitabine—lung cancer	8.22e-05	0.000827	CcSEcCtD
Lidocaine—Visual impairment—Docetaxel—lung cancer	8.19e-05	0.000823	CcSEcCtD
Lidocaine—Dizziness—Topotecan—lung cancer	8.18e-05	0.000823	CcSEcCtD
Lidocaine—Tremor—Paclitaxel—lung cancer	8.17e-05	0.000822	CcSEcCtD
Lidocaine—Hypotension—Irinotecan—lung cancer	8.16e-05	0.000821	CcSEcCtD
Lidocaine—Vomiting—Vinblastine—lung cancer	8.1e-05	0.000815	CcSEcCtD
Lidocaine—Dizziness—Erlotinib—lung cancer	8.1e-05	0.000814	CcSEcCtD
Lidocaine—Dermatitis bullous—Doxorubicin—lung cancer	8.02e-05	0.000807	CcSEcCtD
Lidocaine—Agitation—Paclitaxel—lung cancer	8.02e-05	0.000806	CcSEcCtD
Lidocaine—Headache—Vinblastine—lung cancer	7.98e-05	0.000803	CcSEcCtD
Lidocaine—Angioedema—Paclitaxel—lung cancer	7.97e-05	0.000802	CcSEcCtD
Lidocaine—Hypotension—Gemcitabine—lung cancer	7.95e-05	0.000799	CcSEcCtD
Lidocaine—Eye disorder—Docetaxel—lung cancer	7.94e-05	0.000798	CcSEcCtD
Lidocaine—Oedema—Cisplatin—lung cancer	7.93e-05	0.000797	CcSEcCtD
Lidocaine—Anaphylactic shock—Cisplatin—lung cancer	7.93e-05	0.000797	CcSEcCtD
Lidocaine—Anaphylactoid reaction—Doxorubicin—lung cancer	7.92e-05	0.000796	CcSEcCtD
Lidocaine—Cardiac disorder—Docetaxel—lung cancer	7.88e-05	0.000793	CcSEcCtD
Lidocaine—Flushing—Docetaxel—lung cancer	7.88e-05	0.000793	CcSEcCtD
Lidocaine—Vomiting—Topotecan—lung cancer	7.87e-05	0.000791	CcSEcCtD
Lidocaine—Paraesthesia—Irinotecan—lung cancer	7.84e-05	0.000789	CcSEcCtD
Lidocaine—Loss of consciousness—Etoposide—lung cancer	7.82e-05	0.000787	CcSEcCtD
Lidocaine—Rash—Topotecan—lung cancer	7.8e-05	0.000785	CcSEcCtD
Lidocaine—Hypersensitivity—Vinorelbine—lung cancer	7.8e-05	0.000784	CcSEcCtD
Lidocaine—Dermatitis—Topotecan—lung cancer	7.79e-05	0.000784	CcSEcCtD
Lidocaine—Vomiting—Erlotinib—lung cancer	7.78e-05	0.000783	CcSEcCtD
Lidocaine—Dyspnoea—Irinotecan—lung cancer	7.78e-05	0.000783	CcSEcCtD
Lidocaine—Nervous system disorder—Cisplatin—lung cancer	7.77e-05	0.000782	CcSEcCtD
Lidocaine—Somnolence—Irinotecan—lung cancer	7.76e-05	0.000781	CcSEcCtD
Lidocaine—Headache—Topotecan—lung cancer	7.75e-05	0.00078	CcSEcCtD
Lidocaine—Rash—Erlotinib—lung cancer	7.72e-05	0.000776	CcSEcCtD
Lidocaine—Dermatitis—Erlotinib—lung cancer	7.71e-05	0.000776	CcSEcCtD
Lidocaine—Convulsion—Etoposide—lung cancer	7.71e-05	0.000775	CcSEcCtD
Lidocaine—Angiopathy—Docetaxel—lung cancer	7.71e-05	0.000775	CcSEcCtD
Lidocaine—Hypertension—Etoposide—lung cancer	7.68e-05	0.000773	CcSEcCtD
Lidocaine—Immune system disorder—Docetaxel—lung cancer	7.67e-05	0.000772	CcSEcCtD
Lidocaine—Headache—Erlotinib—lung cancer	7.67e-05	0.000771	CcSEcCtD
Lidocaine—Loss of consciousness—Paclitaxel—lung cancer	7.67e-05	0.000771	CcSEcCtD
Lidocaine—Diplopia—Doxorubicin—lung cancer	7.66e-05	0.000771	CcSEcCtD
Lidocaine—Osteoarthritis—Doxorubicin—lung cancer	7.66e-05	0.000771	CcSEcCtD
Lidocaine—Hyperhidrosis—Cisplatin—lung cancer	7.66e-05	0.000771	CcSEcCtD
Lidocaine—Asthma—Methotrexate—lung cancer	7.65e-05	0.000769	CcSEcCtD
Lidocaine—Paraesthesia—Gemcitabine—lung cancer	7.64e-05	0.000768	CcSEcCtD
Lidocaine—Chills—Docetaxel—lung cancer	7.62e-05	0.000767	CcSEcCtD
Lidocaine—Asthenia—Vinorelbine—lung cancer	7.59e-05	0.000764	CcSEcCtD
Lidocaine—Dyspnoea—Gemcitabine—lung cancer	7.58e-05	0.000763	CcSEcCtD
Lidocaine—CYP1A2—lung—lung cancer	7.58e-05	0.0146	CbGeAlD
Lidocaine—Chest pain—Etoposide—lung cancer	7.57e-05	0.000762	CcSEcCtD
Lidocaine—Nausea—Vinblastine—lung cancer	7.57e-05	0.000761	CcSEcCtD
Lidocaine—Somnolence—Gemcitabine—lung cancer	7.56e-05	0.00076	CcSEcCtD
Lidocaine—Convulsion—Paclitaxel—lung cancer	7.56e-05	0.00076	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Irinotecan—lung cancer	7.54e-05	0.000758	CcSEcCtD
Lidocaine—Hypertension—Paclitaxel—lung cancer	7.53e-05	0.000758	CcSEcCtD
Lidocaine—Pain—Irinotecan—lung cancer	7.47e-05	0.000751	CcSEcCtD
Lidocaine—Chest pain—Paclitaxel—lung cancer	7.43e-05	0.000747	CcSEcCtD
Lidocaine—Hypotension—Cisplatin—lung cancer	7.41e-05	0.000745	CcSEcCtD
Lidocaine—Anxiety—Paclitaxel—lung cancer	7.4e-05	0.000745	CcSEcCtD
Lidocaine—Erythema—Docetaxel—lung cancer	7.39e-05	0.000744	CcSEcCtD
Lidocaine—Nausea—Topotecan—lung cancer	7.35e-05	0.000739	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Gemcitabine—lung cancer	7.34e-05	0.000739	CcSEcCtD
Lidocaine—Confusional state—Etoposide—lung cancer	7.32e-05	0.000737	CcSEcCtD
Lidocaine—ABCB1—respiratory system—lung cancer	7.32e-05	0.0141	CbGeAlD
Lidocaine—CYP3A5—lung—lung cancer	7.31e-05	0.0141	CbGeAlD
Lidocaine—Cardiac arrest—Doxorubicin—lung cancer	7.29e-05	0.000733	CcSEcCtD
Lidocaine—Pain—Gemcitabine—lung cancer	7.27e-05	0.000731	CcSEcCtD
Lidocaine—Nausea—Erlotinib—lung cancer	7.27e-05	0.000731	CcSEcCtD
Lidocaine—CYP2B6—lung—lung cancer	7.27e-05	0.014	CbGeAlD
Lidocaine—Anaphylactic shock—Etoposide—lung cancer	7.26e-05	0.00073	CcSEcCtD
Lidocaine—Dysgeusia—Docetaxel—lung cancer	7.24e-05	0.000728	CcSEcCtD
Lidocaine—Feeling abnormal—Irinotecan—lung cancer	7.19e-05	0.000724	CcSEcCtD
Lidocaine—Confusional state—Paclitaxel—lung cancer	7.18e-05	0.000722	CcSEcCtD
Lidocaine—Back pain—Docetaxel—lung cancer	7.15e-05	0.000719	CcSEcCtD
Lidocaine—Anaphylactic shock—Paclitaxel—lung cancer	7.12e-05	0.000716	CcSEcCtD
Lidocaine—Oedema—Paclitaxel—lung cancer	7.12e-05	0.000716	CcSEcCtD
Lidocaine—Paraesthesia—Cisplatin—lung cancer	7.12e-05	0.000716	CcSEcCtD
Lidocaine—Dyspnoea—Cisplatin—lung cancer	7.07e-05	0.000711	CcSEcCtD
Lidocaine—Hyperhidrosis—Etoposide—lung cancer	7.02e-05	0.000706	CcSEcCtD
Lidocaine—Feeling abnormal—Gemcitabine—lung cancer	7.01e-05	0.000705	CcSEcCtD
Lidocaine—Shock—Paclitaxel—lung cancer	7e-05	0.000705	CcSEcCtD
Lidocaine—Dizziness—Vinorelbine—lung cancer	7e-05	0.000704	CcSEcCtD
Lidocaine—Nervous system disorder—Paclitaxel—lung cancer	6.98e-05	0.000702	CcSEcCtD
Lidocaine—Hyperhidrosis—Paclitaxel—lung cancer	6.88e-05	0.000692	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Cisplatin—lung cancer	6.84e-05	0.000688	CcSEcCtD
Lidocaine—Drowsiness—Methotrexate—lung cancer	6.82e-05	0.000686	CcSEcCtD
Lidocaine—Hypotension—Etoposide—lung cancer	6.79e-05	0.000683	CcSEcCtD
Lidocaine—Pain—Cisplatin—lung cancer	6.78e-05	0.000682	CcSEcCtD
Lidocaine—Vomiting—Vinorelbine—lung cancer	6.73e-05	0.000677	CcSEcCtD
Lidocaine—Rash—Vinorelbine—lung cancer	6.67e-05	0.000671	CcSEcCtD
Lidocaine—Dermatitis—Vinorelbine—lung cancer	6.67e-05	0.000671	CcSEcCtD
Lidocaine—Hypotension—Paclitaxel—lung cancer	6.65e-05	0.000669	CcSEcCtD
Lidocaine—Stomatitis—Methotrexate—lung cancer	6.65e-05	0.000669	CcSEcCtD
Lidocaine—Headache—Vinorelbine—lung cancer	6.63e-05	0.000667	CcSEcCtD
Lidocaine—Dysphagia—Doxorubicin—lung cancer	6.62e-05	0.000666	CcSEcCtD
Lidocaine—Asthma—Doxorubicin—lung cancer	6.62e-05	0.000666	CcSEcCtD
Lidocaine—Feeling abnormal—Cisplatin—lung cancer	6.53e-05	0.000657	CcSEcCtD
Lidocaine—Paraesthesia—Etoposide—lung cancer	6.52e-05	0.000656	CcSEcCtD
Lidocaine—Loss of consciousness—Docetaxel—lung cancer	6.5e-05	0.000654	CcSEcCtD
Lidocaine—Dyspnoea—Etoposide—lung cancer	6.47e-05	0.000651	CcSEcCtD
Lidocaine—Somnolence—Etoposide—lung cancer	6.46e-05	0.000649	CcSEcCtD
Lidocaine—Hypersensitivity—Irinotecan—lung cancer	6.43e-05	0.000647	CcSEcCtD
Lidocaine—Convulsion—Docetaxel—lung cancer	6.41e-05	0.000644	CcSEcCtD
Lidocaine—Paraesthesia—Paclitaxel—lung cancer	6.39e-05	0.000643	CcSEcCtD
Lidocaine—Hypertension—Docetaxel—lung cancer	6.38e-05	0.000642	CcSEcCtD
Lidocaine—Dyspnoea—Paclitaxel—lung cancer	6.35e-05	0.000639	CcSEcCtD
Lidocaine—Somnolence—Paclitaxel—lung cancer	6.33e-05	0.000637	CcSEcCtD
Lidocaine—Chest pain—Docetaxel—lung cancer	6.3e-05	0.000633	CcSEcCtD
Lidocaine—Nausea—Vinorelbine—lung cancer	6.29e-05	0.000632	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Etoposide—lung cancer	6.27e-05	0.000631	CcSEcCtD
Lidocaine—Asthenia—Irinotecan—lung cancer	6.26e-05	0.00063	CcSEcCtD
Lidocaine—Pain—Etoposide—lung cancer	6.21e-05	0.000625	CcSEcCtD
Lidocaine—Haemoglobin—Methotrexate—lung cancer	6.15e-05	0.000619	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Paclitaxel—lung cancer	6.15e-05	0.000618	CcSEcCtD
Lidocaine—Haemorrhage—Methotrexate—lung cancer	6.12e-05	0.000616	CcSEcCtD
Lidocaine—ABCB1—epithelium—lung cancer	6.11e-05	0.0117	CbGeAlD
Lidocaine—Asthenia—Gemcitabine—lung cancer	6.1e-05	0.000614	CcSEcCtD
Lidocaine—Pain—Paclitaxel—lung cancer	6.09e-05	0.000612	CcSEcCtD
Lidocaine—Confusional state—Docetaxel—lung cancer	6.08e-05	0.000612	CcSEcCtD
Lidocaine—Anaphylactic shock—Docetaxel—lung cancer	6.03e-05	0.000607	CcSEcCtD
Lidocaine—Oedema—Docetaxel—lung cancer	6.03e-05	0.000607	CcSEcCtD
Lidocaine—Feeling abnormal—Etoposide—lung cancer	5.98e-05	0.000602	CcSEcCtD
Lidocaine—Shock—Docetaxel—lung cancer	5.94e-05	0.000597	CcSEcCtD
Lidocaine—Nervous system disorder—Docetaxel—lung cancer	5.92e-05	0.000595	CcSEcCtD
Lidocaine—Drowsiness—Doxorubicin—lung cancer	5.91e-05	0.000594	CcSEcCtD
Lidocaine—Visual impairment—Methotrexate—lung cancer	5.9e-05	0.000593	CcSEcCtD
Lidocaine—Feeling abnormal—Paclitaxel—lung cancer	5.87e-05	0.00059	CcSEcCtD
Lidocaine—Hypersensitivity—Cisplatin—lung cancer	5.84e-05	0.000587	CcSEcCtD
Lidocaine—Neuropathy peripheral—Doxorubicin—lung cancer	5.79e-05	0.000582	CcSEcCtD
Lidocaine—Dizziness—Irinotecan—lung cancer	5.77e-05	0.000581	CcSEcCtD
Lidocaine—Urticaria—Etoposide—lung cancer	5.77e-05	0.00058	CcSEcCtD
Lidocaine—Stomatitis—Doxorubicin—lung cancer	5.76e-05	0.000579	CcSEcCtD
Lidocaine—SLC22A5—lymph node—lung cancer	5.72e-05	0.011	CbGeAlD
Lidocaine—Eye disorder—Methotrexate—lung cancer	5.72e-05	0.000576	CcSEcCtD
Lidocaine—Tinnitus—Methotrexate—lung cancer	5.71e-05	0.000574	CcSEcCtD
Lidocaine—Asthenia—Cisplatin—lung cancer	5.69e-05	0.000572	CcSEcCtD
Lidocaine—Cardiac disorder—Methotrexate—lung cancer	5.68e-05	0.000572	CcSEcCtD
Lidocaine—Urticaria—Paclitaxel—lung cancer	5.66e-05	0.000569	CcSEcCtD
Lidocaine—Hypotension—Docetaxel—lung cancer	5.64e-05	0.000567	CcSEcCtD
Lidocaine—Angiopathy—Methotrexate—lung cancer	5.55e-05	0.000559	CcSEcCtD
Lidocaine—Vomiting—Irinotecan—lung cancer	5.55e-05	0.000558	CcSEcCtD
Lidocaine—Immune system disorder—Methotrexate—lung cancer	5.53e-05	0.000556	CcSEcCtD
Lidocaine—Rash—Irinotecan—lung cancer	5.5e-05	0.000554	CcSEcCtD
Lidocaine—Dermatitis—Irinotecan—lung cancer	5.5e-05	0.000553	CcSEcCtD
Lidocaine—Chills—Methotrexate—lung cancer	5.49e-05	0.000553	CcSEcCtD
Lidocaine—Headache—Irinotecan—lung cancer	5.47e-05	0.00055	CcSEcCtD
Lidocaine—Paraesthesia—Docetaxel—lung cancer	5.42e-05	0.000545	CcSEcCtD
Lidocaine—Vomiting—Gemcitabine—lung cancer	5.41e-05	0.000544	CcSEcCtD
Lidocaine—ABCB1—trachea—lung cancer	5.41e-05	0.0104	CbGeAlD
Lidocaine—Bradycardia—Doxorubicin—lung cancer	5.4e-05	0.000543	CcSEcCtD
Lidocaine—Dyspnoea—Docetaxel—lung cancer	5.38e-05	0.000541	CcSEcCtD
Lidocaine—Somnolence—Docetaxel—lung cancer	5.36e-05	0.00054	CcSEcCtD
Lidocaine—Rash—Gemcitabine—lung cancer	5.36e-05	0.000539	CcSEcCtD
Lidocaine—Dermatitis—Gemcitabine—lung cancer	5.36e-05	0.000539	CcSEcCtD
Lidocaine—Hypersensitivity—Etoposide—lung cancer	5.35e-05	0.000538	CcSEcCtD
Lidocaine—Erythema—Methotrexate—lung cancer	5.33e-05	0.000536	CcSEcCtD
Lidocaine—Haemoglobin—Doxorubicin—lung cancer	5.33e-05	0.000536	CcSEcCtD
Lidocaine—Headache—Gemcitabine—lung cancer	5.33e-05	0.000536	CcSEcCtD
Lidocaine—Rhinitis—Doxorubicin—lung cancer	5.31e-05	0.000535	CcSEcCtD
Lidocaine—Haemorrhage—Doxorubicin—lung cancer	5.3e-05	0.000533	CcSEcCtD
Lidocaine—Hypoaesthesia—Doxorubicin—lung cancer	5.27e-05	0.000531	CcSEcCtD
Lidocaine—Hypersensitivity—Paclitaxel—lung cancer	5.25e-05	0.000528	CcSEcCtD
Lidocaine—Dysgeusia—Methotrexate—lung cancer	5.22e-05	0.000525	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Docetaxel—lung cancer	5.21e-05	0.000524	CcSEcCtD
Lidocaine—Asthenia—Etoposide—lung cancer	5.21e-05	0.000524	CcSEcCtD
Lidocaine—Nausea—Irinotecan—lung cancer	5.19e-05	0.000522	CcSEcCtD
Lidocaine—Pain—Docetaxel—lung cancer	5.16e-05	0.000519	CcSEcCtD
Lidocaine—Back pain—Methotrexate—lung cancer	5.16e-05	0.000519	CcSEcCtD
Lidocaine—Visual impairment—Doxorubicin—lung cancer	5.11e-05	0.000514	CcSEcCtD
Lidocaine—Asthenia—Paclitaxel—lung cancer	5.11e-05	0.000514	CcSEcCtD
Lidocaine—Nausea—Gemcitabine—lung cancer	5.05e-05	0.000508	CcSEcCtD
Lidocaine—Vomiting—Cisplatin—lung cancer	5.04e-05	0.000507	CcSEcCtD
Lidocaine—Vision blurred—Methotrexate—lung cancer	5.02e-05	0.000505	CcSEcCtD
Lidocaine—Rash—Cisplatin—lung cancer	5e-05	0.000503	CcSEcCtD
Lidocaine—Dermatitis—Cisplatin—lung cancer	4.99e-05	0.000502	CcSEcCtD
Lidocaine—Feeling abnormal—Docetaxel—lung cancer	4.97e-05	0.0005	CcSEcCtD
Lidocaine—Eye disorder—Doxorubicin—lung cancer	4.95e-05	0.000498	CcSEcCtD
Lidocaine—Tinnitus—Doxorubicin—lung cancer	4.94e-05	0.000497	CcSEcCtD
Lidocaine—Flushing—Doxorubicin—lung cancer	4.92e-05	0.000495	CcSEcCtD
Lidocaine—Cardiac disorder—Doxorubicin—lung cancer	4.92e-05	0.000495	CcSEcCtD
Lidocaine—Angiopathy—Doxorubicin—lung cancer	4.81e-05	0.000484	CcSEcCtD
Lidocaine—Dizziness—Etoposide—lung cancer	4.8e-05	0.000483	CcSEcCtD
Lidocaine—Immune system disorder—Doxorubicin—lung cancer	4.79e-05	0.000482	CcSEcCtD
Lidocaine—Chills—Doxorubicin—lung cancer	4.76e-05	0.000478	CcSEcCtD
Lidocaine—Dizziness—Paclitaxel—lung cancer	4.71e-05	0.000474	CcSEcCtD
Lidocaine—Nausea—Cisplatin—lung cancer	4.71e-05	0.000474	CcSEcCtD
Lidocaine—Convulsion—Methotrexate—lung cancer	4.62e-05	0.000464	CcSEcCtD
Lidocaine—Vomiting—Etoposide—lung cancer	4.62e-05	0.000464	CcSEcCtD
Lidocaine—Erythema—Doxorubicin—lung cancer	4.61e-05	0.000464	CcSEcCtD
Lidocaine—Rash—Etoposide—lung cancer	4.58e-05	0.000461	CcSEcCtD
Lidocaine—Dermatitis—Etoposide—lung cancer	4.57e-05	0.00046	CcSEcCtD
Lidocaine—Headache—Etoposide—lung cancer	4.55e-05	0.000458	CcSEcCtD
Lidocaine—Chest pain—Methotrexate—lung cancer	4.54e-05	0.000456	CcSEcCtD
Lidocaine—Tension—Doxorubicin—lung cancer	4.53e-05	0.000456	CcSEcCtD
Lidocaine—Vomiting—Paclitaxel—lung cancer	4.53e-05	0.000455	CcSEcCtD
Lidocaine—Dysgeusia—Doxorubicin—lung cancer	4.52e-05	0.000455	CcSEcCtD
Lidocaine—Rash—Paclitaxel—lung cancer	4.49e-05	0.000452	CcSEcCtD
Lidocaine—Dermatitis—Paclitaxel—lung cancer	4.49e-05	0.000451	CcSEcCtD
Lidocaine—Nervousness—Doxorubicin—lung cancer	4.48e-05	0.000451	CcSEcCtD
Lidocaine—Back pain—Doxorubicin—lung cancer	4.46e-05	0.000449	CcSEcCtD
Lidocaine—Headache—Paclitaxel—lung cancer	4.46e-05	0.000449	CcSEcCtD
Lidocaine—Hypersensitivity—Docetaxel—lung cancer	4.45e-05	0.000447	CcSEcCtD
Lidocaine—Confusional state—Methotrexate—lung cancer	4.39e-05	0.000441	CcSEcCtD
Lidocaine—Anaphylactic shock—Methotrexate—lung cancer	4.35e-05	0.000438	CcSEcCtD
Lidocaine—Vision blurred—Doxorubicin—lung cancer	4.35e-05	0.000437	CcSEcCtD
Lidocaine—Asthenia—Docetaxel—lung cancer	4.33e-05	0.000436	CcSEcCtD
Lidocaine—Nausea—Etoposide—lung cancer	4.31e-05	0.000434	CcSEcCtD
Lidocaine—ABCB1—bone marrow—lung cancer	4.29e-05	0.00824	CbGeAlD
Lidocaine—Nervous system disorder—Methotrexate—lung cancer	4.27e-05	0.000429	CcSEcCtD
Lidocaine—Agitation—Doxorubicin—lung cancer	4.24e-05	0.000427	CcSEcCtD
Lidocaine—Nausea—Paclitaxel—lung cancer	4.23e-05	0.000425	CcSEcCtD
Lidocaine—Hyperhidrosis—Methotrexate—lung cancer	4.2e-05	0.000423	CcSEcCtD
Lidocaine—Hypotension—Methotrexate—lung cancer	4.06e-05	0.000409	CcSEcCtD
Lidocaine—Loss of consciousness—Doxorubicin—lung cancer	4.06e-05	0.000408	CcSEcCtD
Lidocaine—Convulsion—Doxorubicin—lung cancer	4e-05	0.000402	CcSEcCtD
Lidocaine—Dizziness—Docetaxel—lung cancer	3.99e-05	0.000401	CcSEcCtD
Lidocaine—Hypertension—Doxorubicin—lung cancer	3.98e-05	0.000401	CcSEcCtD
Lidocaine—Chest pain—Doxorubicin—lung cancer	3.93e-05	0.000395	CcSEcCtD
Lidocaine—Anxiety—Doxorubicin—lung cancer	3.92e-05	0.000394	CcSEcCtD
Lidocaine—Paraesthesia—Methotrexate—lung cancer	3.91e-05	0.000393	CcSEcCtD
Lidocaine—ABCB1—lung—lung cancer	3.88e-05	0.00747	CbGeAlD
Lidocaine—Dyspnoea—Methotrexate—lung cancer	3.88e-05	0.00039	CcSEcCtD
Lidocaine—Somnolence—Methotrexate—lung cancer	3.87e-05	0.000389	CcSEcCtD
Lidocaine—Vomiting—Docetaxel—lung cancer	3.84e-05	0.000386	CcSEcCtD
Lidocaine—Rash—Docetaxel—lung cancer	3.81e-05	0.000383	CcSEcCtD
Lidocaine—Dermatitis—Docetaxel—lung cancer	3.8e-05	0.000382	CcSEcCtD
Lidocaine—Confusional state—Doxorubicin—lung cancer	3.8e-05	0.000382	CcSEcCtD
Lidocaine—Headache—Docetaxel—lung cancer	3.78e-05	0.00038	CcSEcCtD
Lidocaine—Anaphylactic shock—Doxorubicin—lung cancer	3.77e-05	0.000379	CcSEcCtD
Lidocaine—Oedema—Doxorubicin—lung cancer	3.77e-05	0.000379	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Methotrexate—lung cancer	3.76e-05	0.000378	CcSEcCtD
Lidocaine—Pain—Methotrexate—lung cancer	3.72e-05	0.000374	CcSEcCtD
Lidocaine—Shock—Doxorubicin—lung cancer	3.71e-05	0.000373	CcSEcCtD
Lidocaine—Nervous system disorder—Doxorubicin—lung cancer	3.69e-05	0.000372	CcSEcCtD
Lidocaine—Hyperhidrosis—Doxorubicin—lung cancer	3.64e-05	0.000366	CcSEcCtD
Lidocaine—Nausea—Docetaxel—lung cancer	3.58e-05	0.000361	CcSEcCtD
Lidocaine—Feeling abnormal—Methotrexate—lung cancer	3.58e-05	0.000361	CcSEcCtD
Lidocaine—Hypotension—Doxorubicin—lung cancer	3.52e-05	0.000354	CcSEcCtD
Lidocaine—Urticaria—Methotrexate—lung cancer	3.46e-05	0.000348	CcSEcCtD
Lidocaine—Paraesthesia—Doxorubicin—lung cancer	3.38e-05	0.00034	CcSEcCtD
Lidocaine—Dyspnoea—Doxorubicin—lung cancer	3.36e-05	0.000338	CcSEcCtD
Lidocaine—Somnolence—Doxorubicin—lung cancer	3.35e-05	0.000337	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Doxorubicin—lung cancer	3.25e-05	0.000327	CcSEcCtD
Lidocaine—Pain—Doxorubicin—lung cancer	3.22e-05	0.000324	CcSEcCtD
Lidocaine—Hypersensitivity—Methotrexate—lung cancer	3.2e-05	0.000322	CcSEcCtD
Lidocaine—Asthenia—Methotrexate—lung cancer	3.12e-05	0.000314	CcSEcCtD
Lidocaine—Feeling abnormal—Doxorubicin—lung cancer	3.1e-05	0.000312	CcSEcCtD
Lidocaine—Urticaria—Doxorubicin—lung cancer	2.99e-05	0.000301	CcSEcCtD
Lidocaine—Dizziness—Methotrexate—lung cancer	2.88e-05	0.000289	CcSEcCtD
Lidocaine—Hypersensitivity—Doxorubicin—lung cancer	2.77e-05	0.000279	CcSEcCtD
Lidocaine—Vomiting—Methotrexate—lung cancer	2.77e-05	0.000278	CcSEcCtD
Lidocaine—Rash—Methotrexate—lung cancer	2.74e-05	0.000276	CcSEcCtD
Lidocaine—Dermatitis—Methotrexate—lung cancer	2.74e-05	0.000276	CcSEcCtD
Lidocaine—Headache—Methotrexate—lung cancer	2.72e-05	0.000274	CcSEcCtD
Lidocaine—Asthenia—Doxorubicin—lung cancer	2.7e-05	0.000272	CcSEcCtD
Lidocaine—ABCB1—lymph node—lung cancer	2.66e-05	0.00511	CbGeAlD
Lidocaine—Nausea—Methotrexate—lung cancer	2.58e-05	0.00026	CcSEcCtD
Lidocaine—Dizziness—Doxorubicin—lung cancer	2.49e-05	0.000251	CcSEcCtD
Lidocaine—Vomiting—Doxorubicin—lung cancer	2.39e-05	0.000241	CcSEcCtD
Lidocaine—Rash—Doxorubicin—lung cancer	2.37e-05	0.000239	CcSEcCtD
Lidocaine—Dermatitis—Doxorubicin—lung cancer	2.37e-05	0.000239	CcSEcCtD
Lidocaine—Headache—Doxorubicin—lung cancer	2.36e-05	0.000237	CcSEcCtD
Lidocaine—Nausea—Doxorubicin—lung cancer	2.24e-05	0.000225	CcSEcCtD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.37e-06	2.44e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—POMC—lung cancer	2.36e-06	2.43e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.35e-06	2.42e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ABCB1—lung cancer	2.35e-06	2.42e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—ALB—lung cancer	2.35e-06	2.42e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—MAPK3—lung cancer	2.34e-06	2.41e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—STK11—lung cancer	2.33e-06	2.41e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ENO1—lung cancer	2.33e-06	2.4e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—UGT1A1—lung cancer	2.33e-06	2.4e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—POMC—lung cancer	2.32e-06	2.4e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.32e-06	2.39e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—SRC—lung cancer	2.32e-06	2.39e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—CDKN1A—lung cancer	2.31e-06	2.38e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—PTEN—lung cancer	2.31e-06	2.38e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—TYMS—lung cancer	2.31e-06	2.38e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—CREBBP—lung cancer	2.3e-06	2.37e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—BRAF—lung cancer	2.3e-06	2.37e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.29e-06	2.36e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—GSTM1—lung cancer	2.28e-06	2.35e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IL6R—lung cancer	2.27e-06	2.34e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CREBBP—lung cancer	2.26e-06	2.33e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GNG11—lung cancer	2.25e-06	2.31e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—STAT3—lung cancer	2.24e-06	2.3e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—NRAS—lung cancer	2.23e-06	2.3e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—EP300—lung cancer	2.2e-06	2.27e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—STK11—lung cancer	2.2e-06	2.27e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—APOA1—lung cancer	2.19e-06	2.26e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—STK11—lung cancer	2.18e-06	2.25e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PIK3CD—lung cancer	2.18e-06	2.24e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MAP2K1—lung cancer	2.16e-06	2.23e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GSTP1—lung cancer	2.16e-06	2.23e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—CYP1A1—lung cancer	2.16e-06	2.23e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—ALB—lung cancer	2.15e-06	2.22e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PIK3CD—lung cancer	2.15e-06	2.21e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ERCC2—lung cancer	2.14e-06	2.21e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—SRC—lung cancer	2.14e-06	2.21e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—APOA1—lung cancer	2.14e-06	2.21e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ALDOA—lung cancer	2.14e-06	2.2e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—MAPK3—lung cancer	2.14e-06	2.2e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CAT—lung cancer	2.1e-06	2.17e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—KRAS—lung cancer	2.1e-06	2.17e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CYP2E1—lung cancer	2.09e-06	2.15e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—NCOA3—lung cancer	2.08e-06	2.14e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PIK3CB—lung cancer	2.07e-06	2.13e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—NQO1—lung cancer	2.07e-06	2.13e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—STAT3—lung cancer	2.07e-06	2.13e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—NRAS—lung cancer	2.06e-06	2.12e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PTGS2—lung cancer	2.05e-06	2.11e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.05e-06	2.11e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GSTP1—lung cancer	2.04e-06	2.1e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.02e-06	2.09e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ADCY1—lung cancer	2.02e-06	2.08e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ABCG2—lung cancer	2.02e-06	2.08e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GSTP1—lung cancer	2.02e-06	2.08e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—TYMS—lung cancer	2.01e-06	2.07e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.01e-06	2.07e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PIK3CG—lung cancer	2e-06	2.06e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GSTM1—lung cancer	1.99e-06	2.05e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CAT—lung cancer	1.98e-06	2.04e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ENO2—lung cancer	1.98e-06	2.04e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—HPGDS—lung cancer	1.98e-06	2.04e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—MAPK3—lung cancer	1.97e-06	2.03e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.97e-06	2.03e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CAT—lung cancer	1.96e-06	2.02e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PIK3CG—lung cancer	1.95e-06	2.01e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.95e-06	2.01e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—PIK3CA—lung cancer	1.93e-06	1.99e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ABCB1—lung cancer	1.93e-06	1.99e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MDM2—lung cancer	1.92e-06	1.98e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—KRAS—lung cancer	1.92e-06	1.98e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GSTT1—lung cancer	1.92e-06	1.98e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—MYC—lung cancer	1.92e-06	1.98e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—RAF1—lung cancer	1.92e-06	1.98e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ABCB1—lung cancer	1.91e-06	1.97e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—POMC—lung cancer	1.9e-06	1.96e-05	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—PIK3CA—lung cancer	1.9e-06	1.96e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PIK3CB—lung cancer	1.9e-06	1.96e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GCLC—lung cancer	1.9e-06	1.96e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CYP2A6—lung cancer	1.9e-06	1.96e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—ERBB2—lung cancer	1.9e-06	1.95e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—TYMS—lung cancer	1.89e-06	1.95e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CYP1A1—lung cancer	1.88e-06	1.94e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PTGS2—lung cancer	1.88e-06	1.94e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—TYMS—lung cancer	1.88e-06	1.93e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MTOR—lung cancer	1.87e-06	1.93e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PIK3CB—lung cancer	1.87e-06	1.93e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GSTM1—lung cancer	1.87e-06	1.93e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—ERCC2—lung cancer	1.87e-06	1.92e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—STK11—lung cancer	1.86e-06	1.92e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—POMC—lung cancer	1.86e-06	1.92e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GSTM1—lung cancer	1.85e-06	1.91e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—APOA1—lung cancer	1.85e-06	1.91e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—CREBBP—lung cancer	1.85e-06	1.91e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—CREBBP—lung cancer	1.81e-06	1.87e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ENO1—lung cancer	1.8e-06	1.85e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CXCL8—lung cancer	1.8e-06	1.85e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PTEN—lung cancer	1.79e-06	1.84e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—HRAS—lung cancer	1.79e-06	1.84e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.77e-06	1.83e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CYP1A1—lung cancer	1.77e-06	1.83e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—KRAS—lung cancer	1.77e-06	1.83e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—PIK3CA—lung cancer	1.76e-06	1.82e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ERCC2—lung cancer	1.76e-06	1.81e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CYP1A1—lung cancer	1.76e-06	1.81e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PIK3CD—lung cancer	1.76e-06	1.81e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.75e-06	1.8e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ERCC2—lung cancer	1.74e-06	1.8e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—ALB—lung cancer	1.73e-06	1.79e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GSTP1—lung cancer	1.72e-06	1.78e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CASP3—lung cancer	1.72e-06	1.77e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IL2—lung cancer	1.72e-06	1.77e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PIK3CD—lung cancer	1.72e-06	1.77e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—IL6—lung cancer	1.71e-06	1.76e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—EP300—lung cancer	1.71e-06	1.76e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—ALB—lung cancer	1.7e-06	1.75e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PIK3CG—lung cancer	1.69e-06	1.74e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CAT—lung cancer	1.68e-06	1.73e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CCND1—lung cancer	1.68e-06	1.73e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—JUN—lung cancer	1.67e-06	1.72e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.67e-06	1.72e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PTEN—lung cancer	1.64e-06	1.69e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ABCB1—lung cancer	1.63e-06	1.68e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—HRAS—lung cancer	1.63e-06	1.68e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—PIK3CA—lung cancer	1.63e-06	1.68e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MMP9—lung cancer	1.63e-06	1.68e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CDKN1A—lung cancer	1.62e-06	1.67e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PTEN—lung cancer	1.62e-06	1.67e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—APOA1—lung cancer	1.61e-06	1.66e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CYP2E1—lung cancer	1.61e-06	1.66e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—POMC—lung cancer	1.61e-06	1.66e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—TYMS—lung cancer	1.6e-06	1.65e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—NQO1—lung cancer	1.6e-06	1.64e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GSTM1—lung cancer	1.58e-06	1.63e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—AKT1—lung cancer	1.58e-06	1.63e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—CREBBP—lung cancer	1.57e-06	1.62e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—EP300—lung cancer	1.56e-06	1.61e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—IL6—lung cancer	1.56e-06	1.61e-05	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—AKT1—lung cancer	1.55e-06	1.6e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—EP300—lung cancer	1.54e-06	1.59e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PIK3CB—lung cancer	1.53e-06	1.58e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—APOA1—lung cancer	1.52e-06	1.57e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PTGS2—lung cancer	1.52e-06	1.56e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—APOA1—lung cancer	1.51e-06	1.55e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—HRAS—lung cancer	1.51e-06	1.55e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CYP1A1—lung cancer	1.5e-06	1.55e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—SRC—lung cancer	1.5e-06	1.55e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PIK3CB—lung cancer	1.5e-06	1.54e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ERCC2—lung cancer	1.49e-06	1.54e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PIK3CD—lung cancer	1.49e-06	1.53e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PTGS2—lung cancer	1.48e-06	1.53e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PIK3CG—lung cancer	1.47e-06	1.52e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ALB—lung cancer	1.47e-06	1.51e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—VEGFA—lung cancer	1.46e-06	1.51e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—STAT3—lung cancer	1.45e-06	1.49e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.44e-06	1.49e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—NRAS—lung cancer	1.44e-06	1.49e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—IL6—lung cancer	1.44e-06	1.49e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—AKT1—lung cancer	1.44e-06	1.49e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—STK11—lung cancer	1.44e-06	1.48e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—POMC—lung cancer	1.4e-06	1.45e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PIK3CG—lung cancer	1.39e-06	1.43e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MAPK3—lung cancer	1.38e-06	1.42e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PIK3CG—lung cancer	1.38e-06	1.42e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CREBBP—lung cancer	1.37e-06	1.41e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MYC—lung cancer	1.34e-06	1.38e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GSTP1—lung cancer	1.33e-06	1.37e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—AKT1—lung cancer	1.33e-06	1.37e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PTEN—lung cancer	1.32e-06	1.36e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—POMC—lung cancer	1.32e-06	1.36e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—POMC—lung cancer	1.31e-06	1.35e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PIK3CB—lung cancer	1.3e-06	1.34e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PIK3CD—lung cancer	1.3e-06	1.34e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CAT—lung cancer	1.3e-06	1.33e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PTEN—lung cancer	1.29e-06	1.33e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—APOA1—lung cancer	1.29e-06	1.33e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CREBBP—lung cancer	1.29e-06	1.33e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PTGS2—lung cancer	1.28e-06	1.32e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—ALB—lung cancer	1.28e-06	1.32e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CREBBP—lung cancer	1.28e-06	1.32e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PIK3CA—lung cancer	1.26e-06	1.3e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—EP300—lung cancer	1.26e-06	1.3e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ABCB1—lung cancer	1.26e-06	1.3e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—KRAS—lung cancer	1.24e-06	1.28e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—TYMS—lung cancer	1.24e-06	1.28e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.23e-06	1.27e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—EP300—lung cancer	1.23e-06	1.27e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GSTM1—lung cancer	1.22e-06	1.26e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PIK3CD—lung cancer	1.22e-06	1.26e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PIK3CD—lung cancer	1.21e-06	1.25e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ALB—lung cancer	1.21e-06	1.24e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ALB—lung cancer	1.2e-06	1.23e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PIK3CG—lung cancer	1.18e-06	1.21e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CYP1A1—lung cancer	1.16e-06	1.19e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PIK3CA—lung cancer	1.16e-06	1.19e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ERCC2—lung cancer	1.15e-06	1.19e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PIK3CA—lung cancer	1.14e-06	1.18e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PIK3CB—lung cancer	1.13e-06	1.16e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PTEN—lung cancer	1.12e-06	1.15e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—POMC—lung cancer	1.12e-06	1.15e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PTGS2—lung cancer	1.12e-06	1.15e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TP53—lung cancer	1.1e-06	1.14e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CREBBP—lung cancer	1.09e-06	1.12e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—EP300—lung cancer	1.07e-06	1.1e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PIK3CB—lung cancer	1.06e-06	1.1e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—HRAS—lung cancer	1.06e-06	1.09e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PIK3CB—lung cancer	1.06e-06	1.09e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PTGS2—lung cancer	1.05e-06	1.09e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PTGS2—lung cancer	1.05e-06	1.08e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PIK3CD—lung cancer	1.03e-06	1.07e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—AKT1—lung cancer	1.03e-06	1.06e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ALB—lung cancer	1.02e-06	1.05e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IL6—lung cancer	1.01e-06	1.04e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—APOA1—lung cancer	9.95e-07	1.03e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PTEN—lung cancer	9.76e-07	1.01e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—AKT1—lung cancer	9.45e-07	9.74e-06	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PIK3CA—lung cancer	9.34e-07	9.62e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—AKT1—lung cancer	9.32e-07	9.6e-06	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—EP300—lung cancer	9.31e-07	9.59e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PTEN—lung cancer	9.2e-07	9.48e-06	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PIK3CA—lung cancer	9.13e-07	9.4e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PTEN—lung cancer	9.12e-07	9.4e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PIK3CG—lung cancer	9.08e-07	9.36e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PIK3CB—lung cancer	9.02e-07	9.29e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PTGS2—lung cancer	8.94e-07	9.21e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—EP300—lung cancer	8.77e-07	9.04e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—EP300—lung cancer	8.7e-07	8.96e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—POMC—lung cancer	8.65e-07	8.91e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CREBBP—lung cancer	8.42e-07	8.68e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PIK3CD—lung cancer	7.98e-07	8.23e-06	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PIK3CA—lung cancer	7.9e-07	8.14e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ALB—lung cancer	7.88e-07	8.12e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PTEN—lung cancer	7.79e-07	8.03e-06	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—AKT1—lung cancer	7.63e-07	7.86e-06	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—AKT1—lung cancer	7.45e-07	7.68e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—EP300—lung cancer	7.43e-07	7.66e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PIK3CB—lung cancer	6.96e-07	7.17e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PTGS2—lung cancer	6.9e-07	7.11e-06	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PIK3CA—lung cancer	6.89e-07	7.1e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PIK3CA—lung cancer	6.49e-07	6.69e-06	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—AKT1—lung cancer	6.46e-07	6.65e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PIK3CA—lung cancer	6.43e-07	6.63e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PTEN—lung cancer	6.01e-07	6.2e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—EP300—lung cancer	5.74e-07	5.91e-06	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—AKT1—lung cancer	5.63e-07	5.8e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PIK3CA—lung cancer	5.5e-07	5.66e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—AKT1—lung cancer	5.3e-07	5.46e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—AKT1—lung cancer	5.26e-07	5.42e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—AKT1—lung cancer	4.49e-07	4.63e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PIK3CA—lung cancer	4.24e-07	4.37e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—AKT1—lung cancer	3.47e-07	3.57e-06	CbGpPWpGaD
